Your browser doesn't support javascript.
loading
Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2.
O'Leary, Patrick C; Chen, Huadong; Doruk, Yagmur U; Williamson, Tess; Polacco, Benjamin; McNeal, Andrew S; Shenoy, Tanushree; Kale, Nupura; Carnevale, Julia; Stevenson, Erica; Quigley, David A; Chou, Jonathan; Feng, Felix Y; Swaney, Danielle L; Krogan, Nevan J; Kim, Minkyu; Diolaiti, Morgan E; Ashworth, Alan.
Afiliación
  • O'Leary PC; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Chen H; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Doruk YU; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Williamson T; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Polacco B; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, California.
  • McNeal AS; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California.
  • Shenoy T; Gladstone Institutes, San Francisco, California.
  • Kale N; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Carnevale J; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Stevenson E; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Quigley DA; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Chou J; Gladstone Institutes, San Francisco, California.
  • Feng FY; Department of Medicine, University of California San Francisco, San Francisco, California.
  • Swaney DL; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, California.
  • Krogan NJ; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California.
  • Kim M; Gladstone Institutes, San Francisco, California.
  • Diolaiti ME; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Ashworth A; Department of Urology, University of California San Francisco, San Francisco, California.
Cancer Res ; 82(21): 3950-3961, 2022 11 02.
Article en En | MEDLINE | ID: mdl-36273492
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Res Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Res Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos